https://www.businesswire.com/news/home/20191028005624/en/

NEWARK, Calif.--(BUSINESS WIRE)--Oct 28, 2019--

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulators for aesthetic and therapeutic indications, today announced that the company will release third quarter 2019 financial results on Monday, November 4, 2019 after the close of market. Revance will host a corresponding conference call and a live webcast at 1:30 p.m. PT/4:30 p.m. ET on the same day to discuss the results and provide a business and pipeline update.